UK markets closed
  • FTSE 100

    7,466.07
    -88.24 (-1.17%)
     
  • FTSE 250

    21,643.30
    -211.27 (-0.97%)
     
  • AIM

    1,082.51
    -4.13 (-0.38%)
     
  • GBP/EUR

    1.2014
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.3401
    +0.0019 (+0.14%)
     
  • BTC-GBP

    28,019.98
    +385.50 (+1.39%)
     
  • CMC Crypto 200

    863.83
    +21.37 (+2.54%)
     
  • S&P 500

    4,431.85
    +105.34 (+2.43%)
     
  • DOW

    34,725.47
    +564.69 (+1.65%)
     
  • CRUDE OIL

    87.29
    +0.68 (+0.79%)
     
  • GOLD FUTURES

    1,792.30
    -2.70 (-0.15%)
     
  • NIKKEI 225

    26,717.34
    +547.04 (+2.09%)
     
  • HANG SENG

    23,550.08
    -256.92 (-1.08%)
     
  • DAX

    15,318.95
    -205.32 (-1.32%)
     
  • CAC 40

    6,965.88
    -57.92 (-0.82%)
     

Cystic Fibrosis Therapy Area Overview 2021: Notable Companies Include Abbvie, Chiesi, Sanofi, ReCode Therapeutics and Viatris

·1-min read

Dublin, Jan. 13, 2022 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis (CF) Therapy Area Report" report has been added to ResearchAndMarkets.com's offering.

Companies Mentioned

  • AbbVie

  • Chiesi

  • Genentech

  • Gilead Sciences

  • Laurent Pharma

  • Nestle Health Science

  • ReCode Therapeutics

  • Sanofi

  • TranslateBio

  • Vertex Pharmaceuticals

  • Viatris

This Cystic Fibrosis (CF) therapy area report offers a comprehensive overview of the CF social media landscape, and provides insight into multiple stakeholder and company perspectives. Understand emergent signals and key trends amongst patients, caregivers, HCPs and digital opinion leaders, as well as the opportunities that exists for pharma to better engage with these groups.

The report, which is based on both machine and human-led analysis, uncovers the personas of online stakeholders, the key unmet needs, and opportunities for pharma to engage with the online customers. Insights from our report can help boost pharma companies' engagement strategies, identify potential opportunities and mitigate business risks.

Key Topics Covered:

CF Social Media Landscape Overview

  • Social Media Conversation Architecture

  • Media Type Characteristics

  • Key Drivers of Conversation

The Patient Voice

  • Overview of Patient and Caregiver Online Conversation in CF

  • Key Patient and Caregiver Online Segments

  • Existing Treatment Unmet Needs

  • Summary and Opportunities from the Patient Conversation

Clinical Conversations

  • Overview of HCP Online Conversation

  • Professional Online Segments

  • Conference Engagement

  • DOL Identification

  • Summary and Opportunities from the Clinical Conversation

Competitive Intelligence

  • Key Company Social Media Activity

  • Analysis of Company Earned vs Owned Online Activity

  • Summary and Opportunities from the Pharma Conversation

For more information about this report visit https://www.researchandmarkets.com/r/kzs1yt

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting